Sam Ellis

Mr. Ellis serves as the Chairman of the Board for January Therapeutics as well as the interim Chief Executive Officer. Mr. Ellis is an entrepreneur, business leader, investor, biochemist and molecular biologist who has worked in the biotechnology industry for over 20 years.

He has successfully grown multiple businesses including Thomson Instrument Company and is listed as inventor on more than 35+ patents. In his career Sam has successfully closed more than 100 deals in biotechnology-focused partnerships with large pharma, small pharma, academic, and government entities. He has collaborated to publish together with Genentech, Pfizer, Takeda, and other companies in ground breaking scientific areas. Sam is a regular speaker at PEP Talk & PEGS, speaking publicly at multiple conferences, and regularly gives technical seminars at companies around the world.

In addition to his executive role at Thomson, Mr. Ellis is actively involved in life science investment firms, including Life Science Angels and Tech Coast Angels. Mr. Ellis educational background is in biochemistry and molecular biology, in which he received his B.S. from the University of California, San Diego. Mr. Ellis is also an inventor holding over 40 patents.